Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$9.33M$9.33Mderived−34.4% vs Q4 2018 Net Income-$6.69M-$6.69MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$4,150,000−55.4% Operating Incomederived-$7,343,000N/M Operating Cash Flowderived-$4,626,000N/M Free Cash Flowderived-$4,872,000N/M Margins · derivedGross margin44.5%−21.0 pt vs Q4 2018
Operating margin-78.7%−98.1 pt vs Q4 2018
Net margin-71.7%−92.1 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end